Amneal Pharmaceuticals Eyes 2026 Growth at JPMorgan, Crexont Sales Seen Doubling in 2025 [Yahoo! Finance]
JP Morgan Chase & Co. (JPM)
Last jp morgan chase & co. earnings: 4/14 06:43 am
Check Earnings Report
US:NYSE Investor Relations:
jpmorganchase.com/corporate/investor-relations/investor-relations.htm
Company Research
Source: Yahoo! Finance
JPMorgan conference to outline its ongoing shift toward higher-value “affordable medicines” and specialty products, while highlighting near-term growth drivers across complex generics, biosimilars, and branded neurology. Co-CEO Chirag Patel said Amneal has evolved from a more traditional retail generics model toward complex dosage forms and products with fewer competitors. He described the “affordable medicines” segment as including retail generics, injectables, and biosimilars, and said the company is “zoomed in focus in the United States,” with about 98% of revenue coming from the U.S., while pursuing select partnerships internationally. ? Inside D-Wave's Major Acquisition—What Changes for Investors 6 reasons to buy Teva Pharmaceuticals stock sooner than later Patel said retail generics became increasingly competitive around 2017–2018 due to a surge in FDA approvals and heavy buyer concentration, contributing to “a race to the bottom.” In response, Amneal reduced exposure to
Show less
Read more
Impact Snapshot
Event Time:
JPM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JPM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JPM alerts
High impacting JP Morgan Chase & Co. news events
Weekly update
A roundup of the hottest topics
JPM
News
- WaFd Bank (WAFD) Q4 Earnings Report Preview: What To Look For [Yahoo! Finance]Yahoo! Finance
- Pardonnez-moi, mon Père [Finance et Investissement (Montreal) (French)]Finance et Investissement
- AI: Short Circuit? [Seeking Alpha]Seeking Alpha
- Gold Rises Toward Record as US Inflation Supports Rate-Cut Bets [Yahoo! Finance]Yahoo! Finance
- JPMorgan Chase & Co. (NYSE:JPM) is now covered by analysts at CICC Research. They set an "outperform" rating on the stock.MarketBeat
JPM
Earnings
- 1/13/26 - Miss
JPM
Sec Filings
- 1/13/26 - Form 424B2
- 1/13/26 - Form 424B2
- 1/13/26 - Form FWP
- JPM's page on the SEC website